2030 - The Future of Medicine: Avoiding a Medical Meltdown
Over the last couple of years, the credit crunch has driven a near-collapse of the world's financial systems. With the benefit of hindsight, many say this could have been predicted and avoided. Over the next 10-20 years, healthcare is headed for its own meltdown: an inability to fund the growth in demand and the appearance of costly new medical technology within the current healthcare systems framework. This 'meltdown' will not be as sudden as that in the world of finance: it will occur over the next 20 years, but the failure of the current sources of healthcare funding to meet our expectations of care quantity and quality will have consequences every bit as serious as the banking crisis. The warning signs are there, the crisis is already being predicted - but is it inevitable, or can it be avoided?
This book offers a penetrating analysis of the underlying problems, and offers some simple, but far-reaching solutions to bring supply and demand back into balance and avoid the meltdown. It is not a contribution to the current political debate but a primer for the changes to the underlying fabric of healthcare if reforms such as "Obamacare" have any chance of sustainable success.
In the course of the book, we confront many topical challenges: How can people be persuaded to manage their own health better?; Can we afford to spend more of today's money on disease prevention and detection, to save future costs?; Will 'personalised medicine' be cheaper, or more expensive?; Are healthcare IT systems a key part of the solution or doomed to be expensive white elephants?; and most importantly: What will the future of healthcare look like, for us and for our children and grandchildren?
To bring the answers to this final question alive, the book uses a fictitious family, the Carters, to illustrate the changes we will see, the dilemmas we will face and the solutions we must strive for. Interspersed between the text are the vignettes of members of the family, their diseases and treatments and how change has affected each of their lives.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Alzheimer’s antibiotic better body body’s brain budgets cancer Carter Family centres challenges choice chronic disease clinical colonoscopy commissioning companies competition complex cost-effective course coverage create CT scan defensive medicine deliver demand developing world devices diabetes diagnostic disease management doctors drug economic effective electronic medical record emergency estimated example expensive funding future gene genome governments health insurance health plan healthcare healthcare system heart hospital imaging impact improve incentives individual infection innovation investment Jane’s levers long-term major meltdown million molecular monitoring Moving care obesity pain pandemic pathways patient Patient-reported outcomes personal health personalized medicine pharmaceutical population prevention primary problem procedures productivity professionals proteins proteomic recently result risk scans screening sequence siRNA specialist specific stem cells surgery symptoms target targeted therapy therapy today’s treatment trials tumour Type II diabetes vaccine virus